Legalization of cannabis and cannabis-derived products continues to grow at the state level. However, laws and regulations can vary greatly from state to state, and its future remains ambiguous at the federal level. Amid the changing legal landscape, this conference aims to provide the latest updates on developments at all levels of government along with practical recommendations for entities in this space. Join leading regulators, attorneys, advocates, and entrepreneurs as they discuss this fascinating and constantly evolving industry that impacts all FDA-regulated products.
- Federal legislation, regulation, and enforcement updates
- State-level developments in legalization and regulation implementation
- Legal and regulatory landscape for medical marijuana and cannabinoid ingredients in foods, dietary supplements, and cosmetics
CANNRA MEMBERS: Apply for waived registration fee.
FDLI is committed to ensuring the 2024 conference is well attended by CANNRA members. Registration fees may be waived for CANNRA members. If granted, in-person or virtual registration is complementary. FDLI staff will be in contact after your application is received.
Internet Explorer and Microsoft Edge are not supported by the checkout process.
Please use Chrome, Firefox, or Safari. If you are unable to use these browsers, please contact us at 202-371-1420 or [email protected] and we will assist you.
Sponsorship opportunities are available. Please let us know if you would like more information.
Andrew J. Kline, Perkins Coie LLP
Kellsi Booth, Turning Point Brands, Inc.
Cheryl Dreyer, Kerry, Inc.
Pamela Nicole Epstein, Terpene Belt Processing, LLC
William Garvin, Buchanan Ingersoll & Rooney PC
Darin Hayakawa, Department of Health – Hawaii
Nicholas Markel, Toscano Consulting Group (TCG)
Lila McKinley, Connecticut Department of Consumer Protection
Deborah Miran, DMiran Consulting
Evelina Norwinski, Arnold & Porter LLP
Jarred Reiling, DLA Piper LLP (US)
Agustin Rodriguez, Troutman Pepper Hamilton Sanders LLP
Daniel Charles Rubenstein, Steptoe LLP
Frederick A. Stearns, Keller and Heckman LLP
Brian Yagi, Johns Hopkins University
Zach Zalewski, U.S. Pharmacopeia
Call For Proposals
FDLI and the Conference Planning Committee thanks contributors for their submissions. If you submitted a proposal, you will be notified of the status of your proposal in mid-February.